A detailed history of Guo Line Advisory Pte LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Guo Line Advisory Pte LTD holds 79,700 shares of VRTX stock, worth $39.3 Million. This represents 3.77% of its overall portfolio holdings.

Number of Shares
79,700
Previous 79,700 -0.0%
Holding current value
$39.3 Million
Previous $37.4 Billion 0.78%
% of portfolio
3.77%
Previous 3.99%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

BUY
$343.0 - $410.68 $27.3 Million - $32.7 Million
79,700 New
79,700 $32.4 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Guo Line Advisory Pte LTD Portfolio

Follow Guo Line Advisory Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guo Line Advisory Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Guo Line Advisory Pte LTD with notifications on news.